Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
November 7, 2017	SC 13G/A	An amendment to the SC 13G filing	0001104659-17-066647.pdf 0001104659-17-066647.rtf 0001104659-17-066647.xls View HTML
October 4, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-003206.pdf 0001562180-17-003206.rtf 0001562180-17-003206.xls View HTML
October 4, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-003207.pdf 0001562180-17-003207.rtf 0001562180-17-003207.xls View HTML
October 4, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-003205.pdf 0001562180-17-003205.rtf 0001562180-17-003205.xls View HTML
October 2, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-003085.pdf 0001562180-17-003085.rtf 0001562180-17-003085.xls View HTML
September 19, 2017	CT ORDER	CT ORDER	9999999997-17-008760.pdf View HTML
August 17, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-002729.pdf 0001562180-17-002729.rtf 0001562180-17-002729.xls View HTML
August 10, 2017	SC 13D/A	An amendment to a SC 13D filing	0001193125-17-254489.pdf 0001193125-17-254489.rtf 0001193125-17-254489.xls View HTML
August 8, 2017	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-17-016542.pdf 0001564590-17-016542.rtf 0001564590-17-016542.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
July 14, 2017	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001193125-17-228620.pdf 0001193125-17-228620.rtf 0001193125-17-228620.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax